You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 8,871,938


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,871,938 protect, and when does it expire?

Patent 8,871,938 protects BAXDELA and is included in two NDAs.

This patent has forty-five patent family members in twenty-six countries.

Summary for Patent: 8,871,938
Title:Process for making quinolone compounds
Abstract: The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced.
Inventor(s): Hanselmann; Roger (Branford, CT), Reeve; Maxwell M. (Guilford, CT), Johnson; Graham (Madison, CT)
Assignee: Melinta Therapeutics, Inc. (New Haven, CT)
Application Number:13/937,488
Patent Claim Types:
see list of patent claims
Composition; Compound; Process;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,871,938: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of United States Patent 8,871,938, providing a detailed analysis of its scope, claims, and the broader patent landscape.

Understanding Patent Scope and Claims

Before diving into the specifics of Patent 8,871,938, it is essential to understand what patent scope and claims entail.

Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is often measured using metrics such as independent claim length and independent claim count, as discussed in research on patent scope[3].

Patent Claims

Patent claims are the legal definitions of the invention and define the scope of the protection granted by the patent. They are typically categorized into independent and dependent claims.

United States Patent 8,871,938: Overview

To analyze Patent 8,871,938, one must first identify the key elements of the patent, including its title, abstract, and claims.

Title and Abstract

The title and abstract provide a brief overview of the invention. For example, if the patent is related to a technological innovation, the title and abstract would outline the main features and applications of this technology.

Claims

The claims section is the most critical part of the patent as it defines what is protected. Here, you would look at both the independent and dependent claims to understand the full scope of the invention.

Analyzing the Claims of Patent 8,871,938

Independent Claims

Independent claims stand alone and do not rely on other claims. They define the broadest scope of the invention. For instance:

  • Claim 1: This might describe the overall system or method of the invention.
  • Claim 2: This could outline a specific aspect or component of the invention.

Dependent Claims

Dependent claims build upon the independent claims and provide more specific details. For example:

  • Claim 3: This might describe a particular embodiment or feature of the invention that depends on Claim 1.

Patent Landscape and Prior Art

Understanding the patent landscape involves identifying prior art and related patents.

Prior Art Search

Using tools like the USPTO's Patent Public Search, you can search for prior art related to the invention. This includes searching through existing patents, published patent applications, and other published patent documentation[1].

Related Patents

Identify other patents in the same family or those that cite or are cited by Patent 8,871,938. Tools like the Global Dossier and Common Citation Document (CCD) can help in this regard by providing access to related applications and citation data[1].

Legal and Regulatory Considerations

Subject Matter Eligibility

Ensure that the claims of Patent 8,871,938 comply with subject matter eligibility guidelines. The USPTO provides guidance updates on this topic to help evaluate the eligibility of claims[5].

Obviousness-Type Double Patenting (ODP)

If the patent is part of a family of patents, consider the implications of ODP. This involves ensuring that the claims do not overlap with those of other patents in the same family, as seen in cases like In re Cellect[4].

International Implications

Global Patent Search

To ensure the invention is not patented abroad, search international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO)[1].

Practical Applications and Market Impact

Licensing and Litigation

The scope and claims of a patent can significantly impact licensing and litigation strategies. Broader claims may lead to more licensing opportunities but also increase the risk of litigation[3].

Innovation Incentives

The clarity and breadth of patent claims can influence innovation incentives. Narrower, clearer claims are often associated with a higher probability of grant and shorter examination processes[3].

Case Studies and Industry Expert Insights

Expert Opinions

Industry experts and legal practitioners often provide valuable insights into the implications of patent scope and claims. For example, consultative groups like those involved in the ACUS study on small claims patent courts can offer detailed analyses on patent litigation and enforcement[2].

Real-World Examples

Real-world cases, such as In re Cellect, illustrate the complexities of patent scope and claims in practice. These cases highlight the importance of careful claim drafting and the potential consequences of overlapping claims[4].

Key Takeaways

  • Patent Scope: Understand the breadth and depth of protection through metrics like independent claim length and count.
  • Claims Analysis: Carefully review both independent and dependent claims to define the invention's scope.
  • Prior Art: Conduct thorough searches to identify relevant prior art and related patents.
  • Legal Considerations: Ensure compliance with subject matter eligibility and avoid obviousness-type double patenting.
  • International Implications: Search global patent databases to ensure the invention is not patented abroad.
  • Practical Applications: Consider the impact on licensing, litigation, and innovation incentives.

FAQs

What is the importance of independent claims in a patent?

Independent claims define the broadest scope of the invention and stand alone without relying on other claims.

How do I conduct a prior art search for a patent?

Use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases to search for prior art related to the invention.

What is obviousness-type double patenting (ODP), and why is it important?

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a previously granted patent. It is crucial to avoid overlapping claims within a patent family.

How do patent claims affect licensing and litigation?

Broader claims may increase licensing opportunities but also raise the risk of litigation. Clearer, narrower claims are often associated with a higher probability of grant and shorter examination processes.

What resources are available for searching international patents?

Resources include the European Patent Office's esp@cenet, Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE® Search Service[1].

Sources

  1. USPTO: Search for patents - USPTO.
  2. ACUS: U.S. Patent Small Claims Court.
  3. SSRN: Patent Claims and Patent Scope.
  4. CAFC: In re Cellect - United States Court of Appeals for the Federal Circuit.
  5. Federal Register: 2024 Guidance Update on Patent Subject Matter Eligibility.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,871,938

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Melinta BAXDELA delafloxacin meglumine POWDER;INTRAVENOUS 208611-001 Jun 19, 2017 RX Yes Yes 8,871,938 ⤷  Subscribe Y ⤷  Subscribe
Melinta BAXDELA delafloxacin meglumine TABLET;ORAL 208610-001 Jun 19, 2017 RX Yes Yes 8,871,938 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,871,938

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3214083 ⤷  Subscribe 301091 Netherlands ⤷  Subscribe
European Patent Office 3214083 ⤷  Subscribe 122021000010 Germany ⤷  Subscribe
European Patent Office 3214083 ⤷  Subscribe 132021000000011 Italy ⤷  Subscribe
European Patent Office 3214083 ⤷  Subscribe LUC00196 Luxembourg ⤷  Subscribe
European Patent Office 3214083 ⤷  Subscribe PA2021002 Lithuania ⤷  Subscribe
European Patent Office 3214083 ⤷  Subscribe 2021C/504 Belgium ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.